西罗莫司对减轻小口径移植血管材料内膜增生的作用
 |
| 第1页 |
参见附件(2950KB，3页)。
[3]Schachner T, Zou Y, Oberhuber A, et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts [J]. Ann Thorac Surg,2005,79(6):2201-2202.
[4]杨岷,陈长志,成少飞,等.牛心包组织工程心脏瓣膜支架脱细胞方法的比较[J].中华胸心血管外科杂志,2005,21(6):349-351.
[5]Wang XN, Chen CZ, Yang M, et al. Implantation of decellularized small-caliber vascular xenografts with and without surface heparin treatment [J]. International Center for Artificial Organs and Transplantation,2007,31(2):99-104.
[6]冯博,夏永辉,石强,等.国产雷帕霉素-肝素洗脱支架的制备及其体外实验研究[J].中国临床医学影像杂志,2008,19(2):94-98.
[7]Yosuke Ishii, Shun-ichiro Sakamoto, Russell T. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency [J]. Thorac Cardiovasc Surg,2008,135:1237-1246.
[8]陈宏林,尤庆生,孟小勇.HPLC法测定组织中雷帕霉素的含量[J].实用医药杂志,2008,25(7):813-814.
[9]王学宁,陈长志,杨岷,等.肝素处理小口径脱细胞异种血管的移植研究[J].中华胸心血管外科杂志,2006,22(5):324-325.
[10]Sousa JE, Costa MA, Abizaid A, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents [J]. Circulation,2005,111(18):2326-2329.
[11]Yosuke Ishii, Russell T. Kronengold, novel bioengineered small caliber vascular graft with excellent one-month patency [J]. Ann Thorac Surg,2007,83:517-525.
[12]Lin PH, Bush RL, Yao Q, et al. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model [J]. Journal of Surgical Research,2004,118(1):45-52.
[13]Conklin BS, Richter ER, Kreutziger KL, et al. Development and evaluation of a novel decellularized vascular xenograft [J]. Med Eng Phys,2002,24(3):173-183.
[14]李冠军,董桂青,金仲品,等.血管内膜增生的研究进展[J].中国医疗前沿,2008,3(2):34-36.
[15]Poon M, Marx SO, Gallo R, et al. Rapamycin inhibits vascular smooth muscle cell migration [J]. J Clin Invest,1996,98(10):2277-2283.
(收稿日期：2010-12-30)
“本文中所涉及到的图表、公式、注解等请以PDF格式阅读”
您现在查看是摘要介绍页，详见PDF附件(2950KB，3页)。